.jpg "Amedisys (NASDAQ: AMED)")
Analysts have been eager to weigh in on the Services sector with new ratings on Amedisys (NASDAQ: AMED) and Reis Inc (NASDAQ: REIS).
Amedisys (NASDAQ: AMED)
Robert W. Baird analyst Matthew Gillmor maintained a Hold rating on Amedisys (NASDAQ: AMED) today and set a price target of $67. The company’s shares closed yesterday at $65.87, close to its 52-week high of $68.50.
According to TipRanks.com, Gillmor is a 4-star analyst with an average return of 10.2% and a 59.1% success rate. Gillmor covers the Services sector, focusing on stocks such as Encompass Health Corporation, Cotiviti Holdings, and R1 RCM Inc.
Amedisys has an analyst consensus of Moderate Buy, with a price target consensus of $72.50.
See today’s analyst top recommended stocks >>
Reis Inc (NASDAQ: REIS)
B.Riley FBR analyst Mike Crawford maintained a Buy rating on Reis Inc (NASDAQ: REIS) today and set a price target of $25. The company’s shares closed yesterday at $20.80.
According to TipRanks.com, Crawford is a 4-star analyst with an average return of 6.9% and a 55.0% success rate. Crawford covers the Consumer Goods sector, focusing on stocks such as CPI Aerostructures, Finjan Holdings, and Kratos Defense.
Reis Inc has an analyst consensus of Moderate Buy, with a price target consensus of $25.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
